SCHEMBL19296381

SCHEMBL19296381

CC(C)C(=O)C[18F]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL800923 1.00
SCHEMBL27466399 0.77
SCHEMBL11289792 0.75
SCHEMBL27699088 0.75
SCHEMBL19689362 0.73
SCHEMBL7532666 0.73
SCHEMBL620412 0.72 CA1 (0.36)
SCHEMBL181668 0.72 CYP2D6 (0.36)
SCHEMBL9220757 0.71
SCHEMBL12663724 0.69 SLC22A6 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180194729-A1 18F - TAGGED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND THEIR USE AS IMAGING AGENTS FOR PROSTATE CANCER DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2018-07-12 US disclosed
US-10016519-B2 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer DEUTSCHES KREBSFORSCHUNGSZENTRIUM (DE) 2018-07-10 US disclosed
US-20170246327-A1 18F-TAGGED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER Ruprecht-Karls-Universität Heidelberg (DE) 2017-08-31 US disclosed